Clinical and epidemiological characteristics of patients with peripheral artery disease undergoing angiography at a tertiary care hospital in Peru
DOI:
https://doi.org/10.20453/rmh.v37i3.7193Keywords:
peripheral arterial disease, angiography, diabetes mellitus, critical limb ischemia, vascular surgeryAbstract
Objective: To describe the clinical and epidemiological characteristics of patients with peripheral artery disease (PAD) who underwent angiography at a tertiary care hospital. Methods: A descriptive, retrospective case-series study. The study included 41 patients with PAD who underwent angiography between August 2020 and September 2023. We evaluated clinical and epidemiological characteristics, the presence of risk factors, history of cardiovascular disease, indications for angiography, GLASS (Global Limb Anatomic Staging System) stages, therapeutic recommendations, and definitive management. Results: The mean age was 65 ± 11 years; 68.29% were male. Diabetes mellitus was the most frequent risk factor (87.80%), and 73.17% had at least two risk factors. A prior history of cardiovascular disease was observed in 14.63%, with cerebrovascular accident being the most common. Chronic limb-threatening ischemia was the predominant indication for angiography (75.61%). Infrapopliteal involvement predominated, with 53.66% classified as GLASS stage 4. Additionally, 60.97% exhibited GLASS stage 0 in the femoropopliteal segment. The most frequent therapeutic recommendation was medical management combined with angioplasty (43.90%), whereas the most common definitive management was medical management combined with amputation (46.34%). Conclusion: In this series of patients with PAD undergoing angiography, diabetes mellitus and chronic limb-threatening ischemia predominated. Advanced infrapopliteal disease was common, and amputation was the most frequent definitive outcome.
Downloads
References
Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: past, present, and future. Am J Med. 2019;132(10):1133-41. doi:10.1016/j.amjmed.2019.04.043
Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(24):e1313-410. doi:10.1161/cir.0000000000001251
Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: diagnosis and treatment. Am Fam Physician [Internet]. 2019;99(6):362-9. Disponible en: https://www.aafp.org/afp/2019/0315/p362
Fowkes FGR, Aboyans V, Fowkes FJI, McDermott MM, Sampson UKA, Criqui MH. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156-70. doi:10.1038/nrcardio.2016.179
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-26. doi:10.1161/CIRCRESAHA.116.303849
Hackler EL 3rd, Hamburg NM, White Solaru KT. Racial and ethnic disparities in peripheral artery disease. Circ Res. 2021;128(12):1913-26. doi:10.1161/CIRCRESAHA.121.318243
Bennett PC, Silverman S, Gill PS, Lip GYH. Ethnicity and peripheral artery disease. QJM. 2009;102(1):3-16. doi:10.1093/qjmed/hcn140
Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433-37. doi:10.2337/diacare.24.8.1433
Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481-85. doi:10.1001/jama.285.19.2481
Thomas PE, Vedel-Krogh S, Nielsen SF, Nordestgaard BG, Kamstrup PR. Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events. J Am Coll Cardiol. 2023;82(24):2265-76. doi:10.1016/j.jacc.2023.10.009
Mantha Y, Asif A, Fath A, Prasad A. Implications of kidney disease in patients with peripheral arterial disease and vascular calcification. Interv Cardiol Clin. 2023;12(4):531-8. doi:10.1016/j.iccl.2023.06.010
Lanzer P, Hannan FM, Lanzer JD, Janzen J, Raggi P, Furniss D, et al. Medial arterial calcification: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(11):1145-65. doi:10.1016/j.jacc.2021.06.049
GBD 2019 Peripheral Artery Disease Collaborators. Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2023;11(10):e1553-65. doi:10.1016/s2214-109x(23)00355-8
You Y, Wang Z, Yin Z, Bao Q, Lei S, Yu J, et al. Global disease burden and its attributable risk factors of peripheral arterial disease. Sci Rep. 2023;13(1):19898. doi:10.1038/s41598-023-47028-5
Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128(12):1818-32. doi:10.1161/CIRCRESAHA.121.318535
Urbano L, Portilla E, Muñoz W, Hofman A, Sierra-Torres CH. Prevalence and risk factors associated with peripheral arterial disease in an adult population from Colombia. Arch Cardiol Mex. 2018;88(2):107-15. doi:10.1016/j.acmx.2017.02.002
Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510-5. doi:10.1161/01.CIR.71.3.510
Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020-30. doi:10.1016/s2214-109x(19)30255-4
Campos G, Condor RM. La etnicidad en el Perú y su naturaleza multidimensional: una propuesta de medición. Desde el Sur. 2022;14(1):1-24. doi:10.21142/DES-1401-2022-0012
Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. doi:10.1016/s0140-6736(13)61249-0
Moya-Salazar J, Pio-Dávila L. Trastornos lipídicos en pacientes hispanoamericanos en el primer nivel de atención sanitaria de Lima, Perú. Rev Cubana Salud Pública [Internet]. 2020;46(1):e1161. Disponible en: https://revsaludpublica.sld.cu/index.php/spu/article/view/1161
Lazo-Porras M, Bernabe-Ortiz A, Quispe R, Málaga G, Smeeth L, Gilman RH, et al. Urbanization, mainly rurality, but not altitude is associated with dyslipidemia profiles. J Clin Lipidol. 2017;11(5):1212-22.e4. doi:10.1016/j.jacl.2017.06.016
Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014;21(6):704-11. doi:10.1177/2047487312452968
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-143. doi:10.1161/CIR.0000000000000625
Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-9. doi:10.1001/jama.295.2.180
Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, et al. Editor's choice: European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication. Eur J Vasc Endovasc Surg. 2024;67(1):9-96. doi:10.1016/j.ejvs.2023.08.067
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6 Suppl):3S-125S.e40. doi:10.1016/j.jvs.2019.02.016
Bontinis V, Bontinis A, Koutsoumpelis A, Giannopoulos A, Ktenidis K. A systematic review and meta-analysis of GLASS staging system in the endovascular treatment of chronic limb-threatening ischemia. J Vasc Surg. 2023;77(3):957-63.e3. doi:10.1016/j.jvs.2022.07.183
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1 Suppl):e33. doi:10.1016/j.ejvs.2019.05.006
Cerqueira LO, Garcia E, Barros AL, Cerqueira JR, Araújo WJ. WIfI classification: the Society for Vascular Surgery lower extremity threatened limb classification system, a literature review. J Vasc Bras. 2020;19:e20190070. doi:10.1590/1677-5449.190070
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alonso Cordova, Aida Rotta, Cesar Del Castillo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors assign their rights to the RMH so that may disseminate the article through the means at their disposal. The journal will provide forms of affidavit of authorship and authorization for the publication of the article, which shall be submitted with the manuscript. Authors retain the right to share, copy, distribute, perform and publicly communicate their article, or part of it, mentioning the original publication in the journal.
